The androgen receptor as a therapeutic target for myelin repair in demyelinating diseases

References

• Kieseier BC, Stuve O. A critical appraisal of treatment decisions in multiple sclerosis--old versus new. Nat. Rev. Neurol. 7, 255–262 (2011).
   PubMed Web of Science ®Google Scholar
• Harsan LA, Steibel J, Zaremba A et al. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J. Neurosci. 28, 14189–14201 (2008).
   PubMed Web of Science ®Google Scholar
• Huang JK, Jarjour AA, Nait OB et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 14, 45–53 (2011).
   PubMed Web of Science ®Google Scholar
• Hussain R, el-Etr M, Gaci O et al. Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 152, 3820–3831 (2011).
   PubMed Web of Science ®Google Scholar
• Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E. Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J. Neurosci. 33, 1759–1772 (2013).
   PubMedGoogle Scholar
• Fancy SP, Baranzini SE, Zhao C et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571–1585 (2009).
   PubMed Web of Science ®Google Scholar
• Tawk M, Makoukji J, Belle M et al. Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J. Neurosci. 31, 3729–3742 (2011).
   PubMed Web of Science ®Google Scholar
• Doncarlos LL, Sarkey S, Lorenz B et al. Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience 138, 801–807 (2006).
   PubMed Web of Science ®Google Scholar
• Finley SK, Kritzer MF. Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J. Neurobiol. 40, 446–457 (1999).
   Google Scholar
• Fargo KN, Foecking EM, Jones KJ, Sengelaub DR. Neuroprotective actions of androgens on motoneurons. Front. Neuroendocrinol. 30, 130–141 (2009).
   Google Scholar
• Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167, 2060–2067 (2001).
   PubMed Web of Science ®Google Scholar
• Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146, 144–152 (2004).
   PubMed Web of Science ®Google Scholar
• Dalal M, Kim S, Voskuhl RR. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159, 3–6 (1997).
   PubMed Web of Science ®Google Scholar
• Matejuk A, Hopke C, Vandenbark AA, Hurn PD, Offner H. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol. 174, 2387–2395 (2005).
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Giesser BS, Tandon V et al. Testosterone treatment in multiple sclerosis: a pilot study. Arch. Neurol. 64, 683–688 (2007).
   PubMed Web of Science ®Google Scholar
• Gold SM, Chalifoux S, Giesser BS, Voskuhl RR. Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J. Neuroinflammation 5, 32 (2008).
   PubMed Web of Science ®Google Scholar
• Ziehn MO, Avedisian AA, Dervin SM, Umeda EA, O’Dell TJ, Voskuhl RR. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J. Neurosci. 32, 12312–12324 (2012).
   PubMed Web of Science ®Google Scholar
• Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 26, 1439–1447 (2006).
   PubMed Web of Science ®Google Scholar
• Perrin JS, Herve PY, Leonard G et al. Growth of white matter in the adolescent brain: role of testosterone and androgen receptor. J. Neurosci. 28, 9519–9524 (2008).
   Google Scholar
• Hussain R, Ghoumari AM, Bielecki B et al. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. Brain 136, 132–146 (2013).
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Kumar N, Sitruk-Ware R. 7alpha-Methyl-19-nortestosterone (MENT(R)): the Population Council’s contribution to research on male contraception and treatment of hypogonadism. Contraception 87, 288–295 (2013).
   PubMed Web of Science ®Google Scholar
• Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain 120, 1067–1076 (1997).
   PubMed Web of Science ®Google Scholar
• Bove R, Musallam A, Healy BC et al. Testosterone and disease severity in men with early relapsing onset multiple sclerosis. Am. Acad. Neurol. Abstracts (2013).
   Google Scholar
• Haring R, Hannemann A, John U et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 97, 408–415 (2012).
   PubMed Web of Science ®Google Scholar